Stock listing and number of record holders
The Clorox Company’s common stock is listed on the New York Stock Exchange, identified by the symbol CLX. As of July 29, 2016, the number of record holders of Clorox’s common stock was 10,995.
Transfer agent, registrar and dividend disbursing agent
Inquiries relating to stockholder records, change of ownership, change of address and the dividend reinvestment/direct stock purchase plan should be sent to:
P.O. Box 30170
College Station, TX 77842-3170
Overnight correspondence should be sent to:
211 Quality Circle, Suite 210
College Station, TX 77845
877-373-6374 or 781-575-2726
TDD 800-952-9245 or 312-588-4110 for hearing impaired
Stockholder information service
Stockholders can call Clorox Stockholder Direct at 888-CLX-NYSE (259-6973) toll-free 24 hours a day to hear news and messages about Clorox, request company materials or get a 20-minute-delayed stock quote. The latest company news is also available at TheCloroxCompany.com.
Dividend reinvestment/direct stock purchase plan
Clorox has authorized Computershare to offer a dividend reinvestment/direct stock purchase plan. Registered stockholders can purchase additional shares. Nonstockholders may join the plan with an initial investment, lump sum or bank debit. Most fees are paid by Clorox. For more information or plan materials, call 888-CLX-NYSE (259-6973) or contact Computershare (see above).
Management report on internal control over financial reporting
Clorox management, under the supervision and with the participation of the chief executive officer and chief financial officer, has assessed the effectiveness of the company’s internal control over financial reporting as of June 30, 2016, and concluded that it is effective. For more information, see Item 9.A. of the company’s Form 10-K for the fiscal year ended June 30, 2016.
2016 financial information
Full financial statements are provided in the company’s 2016 proxy statement. Detailed financial information is available without charge through the following sources:
- The company’s proxy statement is available at TheCloroxCompany.com.
- The company’s annual report on Form 10-K for the fiscal year ended June 30, 2016, is available at TheCloroxCompany.com and through the SEC’s EDGAR database. Printed copies are available by calling 888-CLX-NYSE (259-6973).
Except for historical information, matters discussed in the annual report are forward-looking statements and are based on management’s estimates, assumptions and projections. Actual results could vary materially. Please review the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections in the company’s annual report on Form 10-K for the fiscal year ended June 30, 2016, and subsequent SEC filings, for factors that could affect the company’s performance and cause results to differ materially from management’s expectations. The information in this report reflected management’s estimates, assumptions and projections as of Aug. 16, 2016. Clorox has not made updates since then and makes no representation, express or implied, that the information is still current or complete. The company is under no obligation to update any part of this document.
Comparative stock performance
The graph below compares the cumulative total stockholder return of the Common Stock for the last five fiscal years with the cumulative total return of the Standard & Poor’s 500 Stock Index and a composite index composed of the Standard & Poor’s Household Products Index and the Standard & Poor’s Housewares & Specialties Index (referred to below as the Peer Group) for a five-year period ending June 30, 2016. The composite index is weighted based on market capitalization as of the end of each quarter during each of the last five years. The graph lines merely connect the prices on the dates indicated and do not reflect fluctuations between those dates.
*$100 invested on 6/30/11 in stock or index, including reinvestment of dividends. Fiscal year ending June 30.
Copyright© 2016 S&P, a division of McGraw Hill Financial. All rights reserved.